cd19-targeted car t cells bz019
Generic: CD19-targeted CAR T Cells BZ019
cd19-targeted car t cells bz019: 1 clinical trial tracked.
cd19-targeted car t cells bz019 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about cd19-targeted car t cells bz019, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
A Single Cohort, Open-label, Multicenter, Dose-escalation Study of Safety and Efficacy of BZ019 for Adult CD19 Positive Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Primary endpoint: Number of adverse events
Interventionalopen12 enrolledStarted 2018-06Completion 2021-061 site · ChinaInstitute of Hematology & Blood Diseases Hospital, China